Anthony Altig
Director/Board Member at ASSEMBLY BIOSCIENCES, INC.
Net worth: 8 858 $ as of 2024-03-30
Profile
Mr. Anthony E.
Altig, CPA, is an Independent Director at Assembly Biosciences, Inc. and a Chief Financial Officer at Biotix, Inc. He is on the Board of Directors at Assembly Biosciences, Inc. Mr. Altig was previously employed as an Independent Director by Ventrus Biosciences, Inc., an Independent Director by Trukera Medical, a Chief Financial Officer & Secretary by Biotix Holdings, Inc., an Independent Director by Optimer Pharmaceuticals LLC, an Independent Director by MultiCell Technologies, Inc., a Chief Financial Officer by Diversa Corp., a Chief Financial Officer by Maxim Pharmaceuticals, Inc., a Director-Finance & Administration by EntryPoint, Inc., a Chief Financial Officer by NBC Internet, Inc., a Controller by Lightspan, Inc., a Vice President & Controller by Accelerated Networks, Inc., a Vice President & Controller by Clarent Corp., a Director-Accounting & Controller by Ionis Pharmaceuticals, Inc., a Principal by KPMG LLP, a Vice President by PricewaterhouseCoopers LLP, and a Chief Accounting Officer by USWeb Corp.
He received his undergraduate degree from the University of Hawaii at Manoa.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 666 ( 0.01% ) | 8 858 $ | 2024-03-30 |
Anthony Altig active positions
| Companies | Position | Start |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Director/Board Member | 2011-12-31 |
Former positions of Anthony Altig
| Companies | Position | End |
|---|---|---|
| TEARLAB CORPORATION | Director/Board Member | 2020-07-08 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Director/Board Member | 2013-10-23 |
| MULTICELL TECHNOLOGIES, INC. | Director/Board Member | 2012-10-21 |
Diversa Corp.
 Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Director of Finance/CFO | 2007-05-31 |
Training of Anthony Altig
| University of Hawaii at Manoa | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| MULTICELL TECHNOLOGIES, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| CLARENT CORPORATION | Communications |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Private companies | 10 |
|---|---|
| Maxim Pharmaceuticals, Inc. | Health Technology |
USWeb Corp.
 USWeb Corp. Information Technology ServicesTechnology Services USWeb is a leading strategic Internet services firm helping clients achieve revenue, profit, market share, and customer loyalty objectives through Internet strategies and systems. Originally founded in 1995, USWeb has offices across the United State | Technology Services |
NBC Internet, Inc.
 NBC Internet, Inc. Internet Software/ServicesTechnology Services NBC Internet, Inc. provides integration, multimedia and entertainment via the Internet services. It portfolio of services included Information, Entertainment, Utility, E-commerce and Advertising Services. The company was founded in 1999 and is headquartered in San Francisco, CA. | Technology Services |
Lightspan, Inc.
 Lightspan, Inc. Packaged SoftwareTechnology Services Lightspan, Inc. provides curriculum-based educational software and Internet products and services | Technology Services |
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
TearLab Corporation, Inc.
 TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Escondido, CA. | Health Technology |
Ventrus Biosciences, Inc.
 Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ventrus Biosciences, Inc. is a development stage specialty pharmaceutical company engages in development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoidal disease, anal fissures, and fecal incontinence. Its major pharmaceutical progress made in the gastrointestinal therapeutic areas of gastroesophageal reflux, peptic ulcer disease, and inflammatory bowel disease. Ventrus Biosciences products includes VEN 307 (topical diltiazem), is intended to treat pain associated with anal fissures and VEN 308 (topical phenylephrine), is intended to treat fecal incontinence. The company was founded on October 10, 2005 and is headquartered in New York, NY. | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Anthony Altig
